CLINICAL_TRIALS
trial_result
· 2017-04-17
Clinical Trial Update: Citalopram in Irritable Bowel Syndrome [Phase 2]
Summary
A Phase 2 trial investigating citalopram for irritable bowel syndrome has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Stanford University | Conditions: Irritable Bowel Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2017-04-17